These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 227700)

  • 1. Potentiation by angiotensin converting enzyme inhibitor, SQ, 14225, of the analgesic effect of morphine in mice.
    Türker RK; Ilhan M; Ercan ZS
    Eur J Pharmacol; 1979 Sep; 58(1):99-100. PubMed ID: 227700
    [No Abstract]   [Full Text] [Related]  

  • 2. Adrenal involvement in captopril-induced potentiation of morphine analgesia.
    Das S; Chatterjee TK; Ghosh JJ
    Eur J Pharmacol; 1982 Nov; 85(2):217-20. PubMed ID: 6295781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of the morphine-induced respiratory rate depression by captopril.
    Oktay S; Onur R; Ilhan M; Türker RK
    Eur J Pharmacol; 1981 Mar; 70(3):257-62. PubMed ID: 6262092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations by captopril of pain reactions due to thermal stimulation of the mouse foot: interactions with morphine, naloxone and aprotinin.
    Ercan ZS; Ilhan M; Türker RK
    Eur J Pharmacol; 1980 May; 63(2-3):167-77. PubMed ID: 6155276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of the algogenic action of bradykinin by an inhibitor of angiotensin I converting enzyme, captopril (SQ 14,225).
    Nakano T; Taira N
    Jpn J Pharmacol; 1979 Aug; 29(4):563-71. PubMed ID: 231702
    [No Abstract]   [Full Text] [Related]  

  • 6. The actions of enkephalins are not modified by the "kininase-II" inhibitor captopril.
    Buckett WR
    Eur J Pharmacol; 1979 Aug; 57(2-3):267-71. PubMed ID: 226377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.
    Cascieri MA; Bull HG; Mumford RA; Patchett AA; Thornberry NA; Liang T
    Mol Pharmacol; 1984 Mar; 25(2):287-93. PubMed ID: 6199659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of angiotensin converting enzyme inhibitor (SQ 14225) on renin-angiotesin sytem and haemodynamics (author's transl)].
    Shigetomi S
    Horumon To Rinsho; 1980; 28(5):531-5. PubMed ID: 6248275
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between plasma renin activity and hypotensive effect of captopril in dogs.
    Hamed AT; Lokhandwala MF; Buckley JP; Jandhyala BS
    Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):195-204. PubMed ID: 6994184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of acute administration of an angiotensin converting enzyme inhibitor, captopril (SQ 14,225), on experimentally induced thirsts in rats.
    Barney CC; Katovich MJ; Fregly MJ
    J Pharmacol Exp Ther; 1980 Jan; 212(1):53-7. PubMed ID: 6243360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of central angiotensin I conversion by oral captopril.
    Marson O; Ribeiro AB; Tufik S; Kohlmann O; Ramos OL
    Braz J Med Biol Res; 1981 Apr; 14(1):73-6. PubMed ID: 6272920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
    Shionoiri H; Uneda S; Tochikubo O; Ohonishi T; Harada J; Sesoko S; Goto E; Fujishima S; Kaneko Y
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of SQ 14225, an inhibitor of angiotensin I-converting enzyme, on the granulomatous response to Schistosoma mansoni eggs in mice.
    Weinstock JV; Ehrinpreis MN; Boros DL; Gee JB
    J Clin Invest; 1981 Apr; 67(4):931-6. PubMed ID: 6259216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421.
    Cohen ML; Kurz KD
    J Pharmacol Exp Ther; 1982 Jan; 220(1):63-9. PubMed ID: 6273529
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the mechanism of the hypotensive action of SQ-14225, an angiotensin-converting enzyme inhibitor in anesthetized dogs.
    Jandhyala BS; Nandiwada P; Buckley JP; Lokhandwala MF
    Res Commun Chem Pathol Pharmacol; 1979 Sep; 25(3):429-46. PubMed ID: 228363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypotensive action of angiotensin I converting enzyme inhibitor (SQ 14,225) in nephrectomized dogs.
    Miura K; Abe Y; Yamamoto K
    J Pharmacol Exp Ther; 1982 Jul; 222(1):246-50. PubMed ID: 6177851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme.
    DiNicolantonio R; Dinicolantonio R; Hutchinson JS; Mendelsohn FA; Doyle AE
    Am J Cardiol; 1982 Apr; 49(6):1502-4. PubMed ID: 6280478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
    Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
    J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The measurement of angiotensin-converting enzyme in subjects receiving captopril.
    Roulston JE; MacGregor GA
    N Engl J Med; 1980 Aug; 303(7):397. PubMed ID: 6248782
    [No Abstract]   [Full Text] [Related]  

  • 20. Converting enzyme inhibition in the rat by captopril is accompanied by potentiation of carrageenin-induced inflammation.
    Boura AL; Svolmanis AP
    Br J Pharmacol; 1984 May; 82(1):3-8. PubMed ID: 6329390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.